overall survival

You have access
Prognostic Impact of Proximal Versus Distal Localization in Extremity Long Bone Osteosarcomas
KJETIL BERNER and ØYVIND S. BRULAND

Anticancer Research May 2019, 39 (5) 2459-2466; DOI: https://doi.org/10.21873/anticanres.13365
You have access
The Role of Previous Therapies and Sites of Metastasis as Influencing Factors on Discordance of ER, PR and HER2 Status Between Primary and Metastasized Breast Cancer
CONSTANZE VOGEL, WOLFRAM MALTER, BERND MORGENSTERN, SEBASTIAN LUDWIG, JÖRG JANNE VEHRESCHILD, STEFANIE HAMACHER, PETER MALLMANN, VERENA KIRN and FABINSHY THANGARAJAH

Anticancer Research May 2019, 39 (5) 2647-2659; DOI: https://doi.org/10.21873/anticanres.13389
You have access
Influence of Postoperative Pneumonia on Esophageal Cancer Survival and Recurrence
AYAKO TAMAGAWA, TORU AOYAMA, HIROSHI TAMAGAWA, MIHWA JU, KEISUKE KOMORI, YUKIO MAEZAWA, KAZUKI KANO, KEISUKE KAZAMA, MASAAKI MURAKAWA, YOSUKE ATSUMI, SHO SAWAZAKI, KENTARO HARA, MASAKATSU NUMATA, TSUTOMU SATO, NORIO YUKAWA, MUNETAKA MASUDA and YASUSHI RINO

Anticancer Research May 2019, 39 (5) 2671-2678; DOI: https://doi.org/10.21873/anticanres.13392
You have access
Immune Phenotype Correlates With Survival in Patients With GBM Treated With Standard Temozolomide-based Therapy and Immunotherapy
MARKOS ANTONOPOULOS, STEFAAN W. VAN GOOL, DIMITRA DIONYSIOU, NORBERT GRAF and GEORGIOS STAMATAKOS

Anticancer Research April 2019, 39 (4) 2043-2051; DOI: https://doi.org/10.21873/anticanres.13315
You have access
Prognostic Significance of Time to Castration Resistance in Patients With Metastatic Castration-sensitive Prostate Cancer
HIDEAKI MIYAKE, YUTO MATSUSHITA, HIROMITSU WATANABE, KEITA TAMURA, DAISUKE MOTOYAMA, TOSHIKI ITO, TAKAYUKI SUGIYAMA and ATSUSHI OTSUKA

Anticancer Research March 2019, 39 (3) 1391-1396; DOI: https://doi.org/10.21873/anticanres.13253
You have access
Prognostic Factors in Early-stage NSCLC: Analysis of the Placebo Group in the MAGRIT Study
BYOUNG CHUL CHO, TOMMASO DE PAS, HARALABOS KALOFONOS, QUN WANG, RODRYG RAMLAU, YING CHENG, FABIANA VITIELLO, TANEL LAISAAR, ERIC VALLIÈRES, BARTOSZ KUBISA, SERGEY ORLOV, KEUNCHIL PARK, CHANNA DEBRUYNE and JOHAN VANSTEENKISTE

Anticancer Research March 2019, 39 (3) 1403-1409; DOI: https://doi.org/10.21873/anticanres.13255
You have access
Uptake of ¹⁸F-Fluorodeoxyglucose in Major Salivary Gland Cancer Predicts Survival Adjusting for Pathological Stage
HIDENORI SUZUKI, TSUNEO TAMAKI, MASAMI NISHIO, HOSHINO TERADA, DAISUKE NISHIKAWA, YUSUKE KOIDE, SHINTARO BEPPU and NOBUHIRO HANAI

Anticancer Research February 2019, 39 (2) 1043-1049; DOI: https://doi.org/10.21873/anticanres.13211
You have access
Baseline Tumor Size as a Predictive and Prognostic Factor of Immune Checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer
MASAHIRO KATSURADA, TATSUYA NAGANO, MOTOKO TACHIHARA, TATSUNORI KIRIU, KOICHI FURUKAWA, KIYOKO KOYAMA, TAKEHIRO OTOSHI, REINA SEKIYA, DAISUKE HAZAMA, DAISUKE TAMURA, KYOSUKE NAKATA, NAOKO KATSURADA, MASATSUGU YAMAMOTO, KAZUYUKI KOBAYASHI and YOSHIHIRO NISHIMURA

Anticancer Research February 2019, 39 (2) 815-825; DOI: https://doi.org/10.21873/anticanres.13180
You have access
Chronic Inflammation as a Potential Predictive Factor of Nivolumab Therapy in Non-small Cell Lung Cancer
MARTIN SVATON, MILADA ZEMANOVA, JANA SKRICKOVA, LENKA JAKUBIKOVA, VITEZSLAV KOLEK, JURAJ KULTAN, LEONA KOUBKOVA, ALZBETA BEJCKOVA, FRANTISEK SALAJKA, MICHAL HRNCIARIK, BOHUSLAV MELICHAR, DAVID VRANA, MAREK KONECNY, RENATA CHLOUPKOVA and MILOS PESEK

Anticancer Research December 2018, 38 (12) 6771-6782; DOI: https://doi.org/10.21873/anticanres.13048
You have access
Whole-Brain Radiotherapy (WBRT) for Brain Metastases: Does the Interval Between Imaging and Treatment Matter?
HEINKE C. HANSEN, STEFAN JANSSEN, CATHRIN THIEME, ALEKSEJ PERLOV, STEVEN E. SCHILD and DIRK RADES

Anticancer Research December 2018, 38 (12) 6835-6840; DOI: https://doi.org/10.21873/anticanres.13057

Main menu

User menu

Search

overall survival

Pages